Israel Biotech Fund I L.P. 13D and 13G filings for Ayala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-08 1:54 pm Purchase | 2020-05-12 | 13G | Ayala Pharmaceuticals, Inc. AYLA | Israel Biotech Fund I L.P. | 3,315,119 25.900% | 3,315,119 (New Position) | Filing |